2 hasil untuk "Mario Manunta"
Menampilkan 1–2 · 0,83 detik · RSS
-
Artikel Jurnal
Corrigendum: SGLT2 inhibitor role in cardio-metabolic–renal diseases: a narrative review of recent evidence and their pharmacological, clinical and economic implications
The authors wish to make the following corrections to their article: Manunta M, Bruno GM, Ferrantelli A, Ramirez RF, Nardi F. SGLT2 inhibitor role in cardio-metabolic-renal diseases: a narrative review of recent evidence and their pharmacological, clinical and economic implications. Drugs Context…
-
Artikel Jurnal
SGLT2 inhibitor role in cardio-metabolic-renal diseases: a narrative review of recent evidence and their pharmacological, clinical and economic implications
Cardio-metabolic-renal (CMR) conditions, including type 2 diabetes mellitus, cardiovascular disease and chronic kidney disease, represent some of the most pressing public health challenges of the 21st century. In recent years, sodium–glucose co-transporter 2 (SGLT2) inhibitors (SGLT2is) have…